Skip to main content
OpenTrials
Completed

NCT Number: NCT03364179

IssuEs in Palliative Care for People in Advanced and Terminal Stages of Young-onset and Late-Onset Dementia in GErmany

From a scientific view, palliative care issues in dementia are neglected in Germany. Neither in Germany nor internationally research has been conducted on palliative care issues in young onset dementia (YOD), although significant differences compared to late onset dementia (LOD) are expected. Most international studies have focused on patients in long term care (LTC) facilities but have neglected patients that are cared for at home. We hypothesize that in advanced and terminal stages of YOD and LOD unmet care needs exist and that they differ between YOD and LOD. By prospectively assessing and surveying 200 patients with YOD and LOD in advanced stages who are cared for in LTC facilities and at home and investigating circumstances of death of 100 YOD- and LOD-patients, it is possible 1) to describe symptoms and management, health care utilization, palliative care provision, quality of life and death, elements of advance care planning, family caregivers' needs and satisfaction; 2) to compare YOD and LOD; 3) to develop expert-consensus recommendations derived from study results for the improvement and implementation of strategies and interventions for palliative care provision. 4) to communicate the recommendations nationally and internationally in order to improve and adapt guidelines, to implement the recommendations into daily practice and to give a basis and perspectives for future research projects; to communicate the results to patients and their families in order to counsel and support them in their decision making processes and their dialogue with professional caregivers and physicians.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Zentrum für kognitive Störungen, Psychiatrische Klinik und Poliklinik, Klinikum Rechts der Isar, TU München

München, Bavaria, 81675, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with moderate or severe dementia (CDR = 2 or 3)
  • Patient lives at home or in long term care
  • Patient has got a family caregiver > 18 years
  • Family caregiver has sufficient knowledge of German language
  • Written informed consent of family caregiver
  • Written informed consent of patient or legal representative, respectively
  • Documents of legal representative/ Power of attorney

Exclusion criteria

  • at least one inclusion criterion is not met

Treatment and study plan

Primary outcomes

  1. patient´s quality of life in late stage dementia

    Time frame: Baseline

    Quality of ife in late-stage dementia scale (QUALID-Scale): 11 questions, Score 1 to 5 each, total sum score range 11 to 55, 11 means highest quality of life

  2. patient´s comfort of dying with dementia

    Time frame: Assessment B at the latest 4 months after patient's death

    Comfort assessment of dying with dementia (CAD-EOLD)-Scale: Subscale of End of Life in Dementia Scale (EOLD), 14 symptoms/ conditions during patient´s dying process to be rated by proxy, Score 1-3 each. Total sum score range 14 to 42. 42 means highest level of comfort during dying process.

Secondary outcomes

  1. symptoms and symptom management in late-stage dementia and during the dying process

    Time frame: Assessment A (study inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)

    adapted version of End of Life in Dementia -Symptom Management scale (SM-EOLD); patient´s examination; assessment of drug treatment and non-medical therapies by evaluation of medical files

  2. palliative care provision in late-stage dementia and during the dying process

    Time frame: Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)

    semi-structured interviews with the caregiver to assess the status quo of (palliative) care issues (e.g. availability of general outpatient palliative care (AAPV), specialized outpatient palliative care (SAPV) or palliative care nurses; description of LTC setting; caregivers´experiences with palliative care)

  3. health care utilization in late-stage dementia and during the dying process

    Time frame: Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)

    semi-structured interviews with the caregivers

  4. Caregivers' problems, challenges, barriers, needs, preferences in late-stage dementia and during the dying process

    Time frame: Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)

    open questions to the family caregiver

  5. family caregivers' burden and coping

    Time frame: Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)

    various scales, e.g. the adapted version of Caregiver Strain Index (CSI)

  6. family caregivers´satisfaction with care

    Time frame: Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)

    various scales, e.g. the adapted version of End of life in dementia-Satisfaction with Care, (SWC-EOLD)

Sponsors and collaborators

Lead sponsor

Technical University of Munich

Other

Collaborators

  • Centre Hospitalier Universitaire Vaudois
  • Deutsche Alzheimer Gesellschaft
  • German Federal Ministry of Education and Research
  • Ludwig-Maximilians - University of Munich

Registry information

Official study title

IssuEs in Palliative Care for People in Advanced and Terminal Stages of Young-onset and Late-Onset Dementia in GErmany (EPYLOGE-Study)

Acronym: EPYLOGE

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Dec 6, 2017
Registry last updated
Oct 26, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.